Patent · US Active

Targeted gene modification by parvoviral vectors

US8846387B2 · kind B2 · utility

16Cited by
18References
20Claims
0Family size

Assignee

Inventors

Key dates

Filing dateMay 24, 2011
Grant dateSep 30, 2014
Priority date
Expiry dateMay 24, 2031

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2750/14143
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

This invention provides methods for obtaining targeted gene modification in vertebrate cells using parvoviral vectors, including adeno-associated virus (AAV). The parvoviral vectors used in the methods of the invention are capable of targeting a specific genetic modification to a preselected target locus in a cellular genome by homologous pairing.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.